Severe sensory neuropathy associated with long-term linezolid use.
Zivkovic
Sasa A
SA
Department of Neurology, University of Pittsburgh School of Medicine, PA, USA. zivkovics@upmc.edu
Lacomis
David
D
D000081:Acetamides / Q000008:administration & dosage / Q000009:adverse effects*; D000328:Adult; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects; D004334:Drug Administration Schedule; D005260:Female; D005727:Ganglia, Spinal / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D000069349:Linezolid; D018908:Muscle Weakness / Q000139:chemically induced; D009437:Neuralgia / Q000139:chemically induced; D009475:Neurons, Afferent / Q000187:drug effects / Q000473:pathology; D009498:Neurotoxins / Q000008:administration & dosage / Q000009:adverse effects; D009900:Optic Nerve / Q000503:physiopathology; D010019:Osteomyelitis / Q000188:drug therapy / Q000382:microbiology; D023303:Oxazolidinones / Q000008:administration & dosage / Q000009:adverse effects*; D010525:Peripheral Nerves / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D012678:Sensation Disorders / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D020886:Somatosensory Disorders / Q000139:chemically induced; D013203:Staphylococcal Infections / Q000188:drug therapy; D013997:Time Factors; D014786:Vision Disorders / Q000139:chemically induced
D000081:Acetamides; D000890:Anti-Infective Agents; D009498:Neurotoxins; D023303:Oxazolidinones; D000069349:Linezolid